EGFR and neoplasm: Patterns of tumor ploidy and allelic imbalances between mutational groups were evaluated by GAP [30] analysis of 141 tumors (n=43 EGFR-mutated, 39 KRAS-mutated, and 59 EGFRwt/KRASwt) profiled by SNP microarrays.